A Phase I, Randomized, Placebo Controlled, Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2010
At a glance
- Drugs PF 4455242 (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 08 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2009 New trial record